Organoborane-catalysed approaches to biologically active amines

有机硼烷催化制备生物活性胺的方法

• 批准号: EP/Y00146X/1
• 负责人: Alexander Pulis
• 金额: $ 58.07万
• 依托单位: University of Leicester
• 依托单位国家: 英国
• 项目类别: Research Grant
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=EP%2FY00146X%2F1
• 关键词: Organoborane; catalysed; approaches; biologically; active

In order to discover a new medicine, academic and industrial researchers require access to diverse collections of molecules. However, the slow step in medicine discovery is the synthesis of these biologically active molecules from simpler building blocks. In many cases, key molecules are inaccessible with current technologies, which prevents researchers exploring the full range of chemical structures required to understand and develop a new medicine. Around 80% of the molecules used in the drug discovery process contain a nitrogen atom (in the form of amines), and therefore novel methods that generate new amine structures are highly valued in the drug discovery arena. In this project, we will explore the unique reactivity of organoboranes to develop a novel and general catalytic platform for the synthesis of amines. Organoboranes have an unusual ability to abstract hydride from amines, generating a reactive cationic intermediate and a hydride bound to boron. This unique reactivity will allow common and readily available building blocks to be used in novel processes. The methods discovered in the project will be easy to use and not require special training. It will also generate low waste through high atom economy. The project will demonstrate the utility of these new tools to targeted end-users in academia, and pharmaceutical and supporting Contract Research industries, by solving specific challenges in drug discovery. For example, by addressing limitations in the synthesis of nitrogen-containing molecules, we will enable access to new and previously inaccessible structures. This will transform medicinal and biological chemists' abilities by enabling them to develop clear pictures of structure-activity relationships that are critical for studying disease and developing new treatments.The project is divided into three Aims that represent the three reaction classes where we will employ the unique abilities of organoboranes to solve challenges.- Aim 1 will target the first direct and modular synthesis of privileged aryl alkyl amines found in serotonergic/dopaminergic pharmaceuticals that treat a variety of mental illnesses. This Aim will enable efficient access to aryl alkyl amines and allow a full and systematic study of how structure affects activity and therefore lead to more efficacious treatments.- Aim 2 will develop a new approach to the catalytic alpha CH arylation of amines. We will demonstrate utility of this method in the late-stage-functionalisation of a variety of validated medicines so that new or improved bioactivity can be efficiently discovered from known molecular templates.- Aim 3 will develop a new approach to the synthesis of a common class of bioactive N- heterocycles, tetrahydroquinolines. We will address specific limitations of current methods and will enable the rapid exploration of chemical space for structure activity relationships related to treatments for cancer, pain, osteoporosis, parasite infections and allergies for the first time.

为了发现一种新药，学术和工业研究人员需要获得不同的分子集合。然而，药物发现的缓慢步骤是从更简单的构建模块合成这些生物活性分子。在许多情况下，目前的技术无法获得关键分子，这阻碍了研究人员探索理解和开发新药所需的全部化学结构。在药物发现过程中使用的大约80%的分子含有氮原子（以胺的形式），因此产生新的胺结构的新方法在药物发现竞技场中具有很高的价值。在本计画中，我们将探索有机硼烷独特的反应活性，以开发一种新颖且通用的胺合成催化平台。有机硼烷具有从胺中提取氢化物的不寻常的能力，产生反应性阳离子中间体和与硼结合的氢化物。这种独特的反应性将允许在新工艺中使用常见且容易获得的结构单元。该项目中发现的方法将易于使用，不需要特殊培训。它还将通过高原子经济性产生低废物。该项目将通过解决药物发现中的具体挑战，向学术界、制药和支持合同研究行业的目标最终用户展示这些新工具的实用性。例如，通过解决含氮分子合成中的限制，我们将能够获得新的和以前无法获得的结构。这将改变药物和生物化学家的能力，使他们能够开发出对研究疾病和开发新疗法至关重要的结构-活性关系的清晰图像。该项目分为三个目标，代表三个反应类别，我们将利用有机硼烷的独特能力来解决挑战。目标1将针对在治疗各种精神疾病的多巴胺能/多巴胺能药物中发现的特权芳基烷基胺的第一次直接和模块化合成。这一目标将使有效地获得芳基烷基胺，并允许全面和系统地研究结构如何影响活性，从而导致更有效的治疗。目的二是开发一种新的胺的催化α-CH芳基化反应方法。我们将证明这种方法在各种验证药物的后期功能化中的实用性，以便从已知的分子模板中有效地发现新的或改进的生物活性。目的三是发展一种合成具有生物活性的N-杂环化合物四氢喹啉的新方法。我们将解决当前方法的具体限制，并将使化学空间的快速探索与癌症，疼痛，骨质疏松症，寄生虫感染和过敏的治疗有关的结构活性关系的第一次。